Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
COMPASS is a prospective multicenter randomized interventional trial. Participants with ductal-dependent pulmonary blood flow will be randomized to receive either a systemic-to-pulmonary artery shunt or ductal artery stent. Block randomization will be performed by center and by single vs. two ventricle status. Participants will be followed through the first year of life.
Epistemonikos ID: 5efd94cbddaf3d8337b4a7aef3cfef569fa31e1c
First added on: May 10, 2024